Abdominal obesity as a predictor for response to anti-vascular endothelial growth factor therapy in patients with diabetic macular edema
Background and aim Diabetic macular edema (DME) is a major cause of visual disturbance among diabetic patients. Anti-vascular endothelial growth factor (anti-VEGF) therapy has been widely used to treat DME. Obesity is associated with higher levels of circulating VEGF, which may worsen diabetic retin...
Saved in:
Main Authors: | Tamer E. Wasfy, Shaimaa S. Soliman, Nehad Hawash, Elham A. Gad |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Journal of the Egyptian Ophthalmological Society |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ejos.ejos_25_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Crocin Monotherapy in Non-Central Diabetic Macular Edema
by: Mojtaba Mojtahedzadeh, et al.
Published: (2024-12-01) -
Ultrastructural imaging biomarkers in diabetic macular edema: A major review
by: Sagnik Sen, et al.
Published: (2025-01-01) -
Outcomes of intravitreal dexamethasone implant (Ozurdex®) in patients with post-surgical macular edema – a real-world scenario
by: Elder Ohara de Oliveira Júnior, et al.
Published: (2025-01-01) -
Modern view on the treatment of diabetic macular edema
by: A.V. Shelankova, et al.
Published: (2022-07-01) -
Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2025-01-01)